Journal of Antimicrobial Chemotherapy, Vol 40, 295-297, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
V Heinemann, D Bosse, U Jehn, A Debus, K Wachholz, H Forst and W Wilmanns
Plasma and tissue concentrations of amphotericin B were determined in a
patient treated with liposomal amphotericin B during liver transplant
failure. A cumulative rise in amphotericin B plasma concentrations was
observed accompanied by an enhanced pulmonary deposition of the drug.
Failure of the liver as a major component of the reticuloendothelial system
may cause elevated plasma concentrations of liposomal amphotericin B and
may consequently enhance deposition of liposomes in the lungs as a
substitutive clearing organ.
ORIGINAL ARTICLES
Enhanced pulmonary accumulation of liposomal amphotericin B (AmBisome) in acute liver transplant failure
Klinikum Grosshadern, III Medical Clinic, University of Munich, Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Smith, J. A. Olson, D. Constable, J. Schwartz, R. T. Proffitt, and J. P. Adler-Moore Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B J. Antimicrob. Chemother., May 1, 2007; 59(5): 941 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vogelsinger, S. Weiler, A. Djanani, J. Kountchev, R. Bellmann-Weiler, C. J. Wiedermann, and R. Bellmann Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion J. Antimicrob. Chemother., June 1, 2006; 57(6): 1153 - 1160. [Abstract] [Full Text] [PDF] |
||||
